Paydirt
AM
Insider

Anand Mehra

Director

Anand Mehra (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in ACRS. Across 1 priced purchase filing, the average 21-session return was -17.0% from execution and -37.6% from disclosure (delay-adjusted; derived). The largest single filing was $1.5M of ACRS (666,666 sh × $2.25, as filed), executed Nov 19 2024. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
-17.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-37.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 19 2024
Filed Nov 20 2024
Open performance→
Most traded names
ACRS ACRS 1 buy · 0 sells 1 filing
Recent filings
ACRSPURCHASE Aclaris Therapeutics, Inc. View filing → $1.5M
666,666 sh × $2.25
Exec Nov 19 2024
Filed Nov 20 2024 · 5:30 PM ET